Usefulness of biomarkers of exposure to inorganic mercury, lead, or cadmium in controlling occupational and environmental risks of nephrotoxicity

Renal Failure

Volumn 21, Issue 3-4, 1999, Pages 251-262

  Roels, Harry A ^a   Hoet, Perrine ^a   Lison, Dominique ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Biomarkers of exposure; Cadmium; Lead; Mercury; Nephrotoxicity

Indexed keywords

BIOLOGICAL MARKER; CADMIUM; CREATININE; ICOSANOID; LEAD; MERCURY; PROSTAGLANDIN;

CONFERENCE PAPER; CREATININE CLEARANCE; CREATININE URINE LEVEL; ENVIRONMENTAL EXPOSURE; GLOMERULUS FILTRATION RATE; HEAVY METAL POISONING; HUMAN; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FUNCTION; LEAD BLOOD LEVEL; NEPHROTOXICITY; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROSTAGLANDIN URINE LEVEL; URINALYSIS;

EID: 0032984143     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229909085087     Document Type: Conference Paper

References (57)

1. Rom WN: Environmental and Occupational Medicine, 2nd ed. Boston, Little-Brown and Company, 1992, pp. 735-772.
2. Price RG, Taylor SA, Chivers I, et al: Development and validation of new screening tests for nephrotoxic effects. Human Exp Toxicol 15 (Suppl 1): S10-S19, 1996.
3. Lauwerys RR, Bernard A: Early detection of nephrotoxic effects of industrial chemicals: state of the art and future prospects. Am J Ind Med 11:275-285, 1987.
4. Mueller PW, Price RG, Finn WF: New approaches for detecting thresholds of human nephrotoxicity using cadmium as an example. Environ Health Perspect 106:227-230, 1998.
5. Roels HA, Lauwerys RR, Buchet JP, et al: In vivo measurement of liver and kidney cadmium in workers exposed to this metal: Its significance with respect to cadmium in blood and urine. Environ Res 26:217-240, 1981.
6. Roels H, Lauwerys R, Konings J, et al: Renal function and hyperfiltration capacity in lead smelter workers with high bone lead. Occup Environ Med 51:505-512, 1994.
7. Börjesson J, Barregard L, Sällsten G, et al: In vivo XRF analysis of mercury: the relation between concentrations in the kidney and the urine. Phys Med Biol 40:413-426, 1995.
8. Roels H, Konings J, Green S, et al: Time-integrated blood lead concentration is a valid surrogate for estimating the cumulative lead dose assessed by tibial lead measurement. Environ Res 69:75-82, 1995.
9. WHO-IPCS: Environmental Health Criteria 118, Inorganic Mercury. Geneva, WHO, 1991, pp 84-107.
10. Buchet JP, Roels H, Bernard A, Lauwerys R: Assessment of renal function of workers exposed to inorganic lead, cadmium or mercury vapor. J Occup Med 22:741-750, 1980.
11. Roels H, Gennart JP, Lauwerys R, et al: Surveillance of workers exposed to mercury vapour: validation of a previously proposed biological threshold limit value for mercury concentration in urine. Am J Ind Med 7:45-71, 1985.
12. Cardenas A, Roels H, Bernard AM, et al: Markers of early renal changes induced by industrial pollutants. I. Application to workers exposed to mercury vapour. Br J Ind Med 50:17-27, 1993.
13. Stewart WK, Guirgis HA, Sanderson J, Taylor W: Urinary mercury excretion and proteinuria in pathology laboratory staff. Br J Ind Med 34:26-31, 1977.
14. Roels HA, Boeckx M, Ceulemans E, Lauwerys RR: Urinary excretion of mercury after occupational exposure to mercury vapour and influence of the dictating agent meso-2,3-dimercaptosuccinic acid (DMSA). Br J Ind Med 48:247-253, 1991.
15. Crutcher JC: Clinical manifestations and therapy of acute lead intoxication due to the ingestion of illicitly distilled alcohol. Ann Intern Med 59:707-715, 1963.
16. Lilis R, Gavrilescu N, Nestorescu B, et al: Nephropathy in chronic lead poisoning. Br J Ind Med 25:196-202, 1968.
17. Wedeen RP, Maesaka JK, Weiner B, et al: Occupational lead nephropathy. Am J Med 59: 630-641, 1975.
18. Inglis JA, Henderson DA, Emmerson BT: The pathology and pathogenesis of chronic lead nephropathy occurring in Queensland. J Pathol 124:65-76, 1978.
19. Gennart JP, Bernard A, Lauwerys R: Assessment of thyroid, testes, kidney and autonomic nervous system function in lead-exposed workers. Int Arch Occup Environ Health 64:49-57, 1992.
20. Omae K, Sakurai H, Higashi T, et al: No adverse effects of lead on renal function in lead-exposed workers. Ind Health 23:77-83, 1990.
21. Gerhardsson L, Chettle DR, Englyst V, et al: Kidney effects in long term exposed lead smelter workers. Br J Ind Med 49:186-192, 1992.
22. Cardenas A, Roels H, Bernard AM, et al: Markers of early renal changes induced by industrial pollutants. II. Application to workers exposed to lead. Br J Ind Med 50:28-36, 1993.
23. Boscolo P, Porielli G, Cecchetti G, et al: Urinary kallikrein activity of workers exposed to lead. Br J Ind Med 35:226-229, 1978.
24. Chmielnicka J, Komsta-Szumska E, Szymanska JA: Arginase and kallikrein activities as biochemical indices of occupational exposure to lead. Br J Ind Med 38:175-178, 1981.
25. Meyer BR, Fischbein A, Rosenman K, et al: Increased urinary enzyme excretion in workers exposed to nephrotoxic chemicals. Am J Med 76:989-998, 1984.
26. Verschoor M, Wibowo A, Herber F, et al: Influence of occupational low-level lead exposure on renal parameters. Am J Ind Med 12:341-351, 1987.
27. Coratelli P, Giannattasio M, Lomonte C, et al: Enzymuria to detect tubular injury in workers exposed to lead: a 12 month follow-up. Contrib Nephrol 68:207-211, 1988.
28. Chia KS, Mutti A, Tan C, et al: Urinary N-acetyl-β-D-glucosaminidase activity in workers exposed to inorganic lead. Occup Environ Med 51:125-129, 1994.
29. Roels HA, Lauwerys RR, Buchet JP, et al: Urinary kallikrein activity in workers exposed to cadmium, lead, or mercury vapour. Br J Ind Med 47:331-337, 1990.
30. Roels H, Bernard A, Lauwerys R: Urinary N-acetyl-β-D-glucosaminidase (NAG) and exposure to inorganic lead (Reply). Occup Environ Med 52:286-287, 1995.
31. Council Directive of 28 July 1982 on the protection of workers from the risks related to exposure to metallic lead and its ionic compounds at work (first individual Directive within the meaning of Article 8 of Directive 80/1107/EEC) (82/605/EEC). Official J Eur Community 25: N° L247/12-21 (23.8.82), 1982.
32. Staessen JA, Lauwerys RR, Buchet JP, et al: Impairment of renal function with increasing blood lead concentrations in the general population. N Engl J Med 327:151-156, 1992.
33. Payton M, Hu H, Sparrow D, Weis ST: Low-level lead exposure and renal function in the normative aging study. Am J Epidemiol 140:821-829, 1994.
34. Emmerson BT, Lecky DS: The lead content of bone in subjects without recognised past lead exposure and in patients with renal disease. Australas Ann Med 12:139-142, 1963.
35. Campbell BC, Elliott HL, Meredith PA: Lead exposure and renal failure: does renal insufficiency influence lead kinetics? Toxicol Lett 9:121-124, 1981.
36. Batuman V, Landy E, Maesaka JK, Wedeen RP: Contribution of lead to hypertension with renal impairment. N Engl J Med 309:17-21,1983.
37. American Council on Science and Health (ACSH): Lead and Human Health. New York, ACSH, 1997, pp 1-37.
38. WHO-IPCS: Environmental Health Criteria 134, Cadmium. Geneva, WHO, 1992, pp 132-146.
39. Bernard A, Buchet JP, Roels H, et al: Renal excretion of proteins and enzymes in workers exposed to cadmium. Eur J Clin Invest 9:11-22, 1979.
40. Bernard AM, Roels H, Cardenas A, Lauwerys R: Assessment of urinary protein 1 and transform as early markers of cadmium nephrotoxicity. Br J Ind Med 47:559-565, 1990.
41. Roels H, Lauwerys R, Dardenne AN: The critical level of cadmium in human renal cortex: a re-evaluation. Toxicol Lett 15:357-360, 1983.
42. Roels H, Bernard AM, Cardenas A, et al: Markers of early renal changes induced by industrial pollutants. III. Application to workers exposed to cadmium. Br J Ind Med 50: 37-48, 1993.
43. Roels H, Djubgang J, Buchet JP, et al: Evolution of cadmium-induced renal dysfunction in workers removed from exposure. Scand J Work Environ Health 8:191-200, 1982.
44. Roels HA, Lauwerys RR, Buchet JP, et al: Health significance of cadmium induced renal dysfunction: a five-year follow up. Br J Ind Med 46:755-764, 1989.
45. Roels HA, Lauwerys RR, Bernard AM, et al: Assessment of the filtration reserve capacity of the kidney in workers exposed to cadmium. Br J Ind Med 48: 365-374, 1991.
46. Roels HA, Van Assche FJ, Oversteyns M, et al: Reversibility of microproteinuria in cadmium workers with incipient tubular dysfunction after reduction of exposure. Am J Ind Med 31: 645-652, 1997.
47. American Conference of Governmental Industrial Hygienists (ACGIH): Supplement: Cadmium and Inorganic Compounds. Biological Exposure Indices, Cincinnati, ACGIH, 1996.
48. Roels HA, Lauwerys R, Buchet JP, Bernard A: Environmental exposure to cadmium and renal function of aged women in three areas of Belgium. Environ Res 24:117-130, 1981.
49. Lauwerys R, Dewals P: Environmental pollution by cadmium and mortality from renal diseases. Lancet i: 383, 1981.
50. Lauwerys R, Hardy R, Job M, et al: Environmental pollution by cadmium and cadmium body burden: an autopsy study. Toxicol Lett 23:287-289, 1984.
51. Lauwerys R, Amery A, Bernard A, et al: Health effects of environmental exposure to cadmium: objectives, design and organization ofthe Cadmibel study: a cross-sectional morbidity study carried out in Belgium from 1985 to 1989. Environ Health Perspect 87: 283-289, 1990.
52. Buchet JP, Lauwerys R, Roels H, et al: Renal effects of cadmium body burden of the general population. Lancet 336:699-702, 1990.
53. Sartor FA, Rondia DJ, Claeys FD, et al: Impact of environmental cadmium pollution on cadmium exposure and body burden. Arch Environ Health 47:347-353, 1992.
54. Staessen JA, Lauwerys RR, Ide G, et al: Renal function and historical environmental cadmium pollution from zinc smelters. Lancet 343:1523-1527, 1994.
55. Staessen J, Amery A, Bernard A, et al: Effects of exposure to cadmium on calcium metabolism: a population study. Br J Ind Med 45:710-714, 1991.
56. Staessen JA, Roels HA, Emelianov D, et al: Environmental exposure to cadmium, forearm bone density and risk of fractures: a prospective population study in Belgium. Lancet 353:1140-1144, 1999.
57. Staessen JA, Kuznetsova T, Emelianov D, et al: Environmental exposure to cadmium and conventional and ambulatory blood pressures in a prospective population study. Am J Hypertens (submitted).